SEC Tracker
Get the app
ZBH · XBRL financial data

Zimmer Biomet Holdings financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (ZBH's year ends in late December)

In millions of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue from contracts with customers1,7541,940*1,8891,9421,8242,023*1,9092,0772,0012,244*2,0872,177
Cost of goods and services sold519539*512554539587*550592559792*576636
Selling, general and administrative675722*736737710747*759815811872*850899
Operating income (loss)267354*266351280389*292300351155*373326
Other income (expense)4(20)*(0)25(38)*34315*(3)2
Income tax expense (benefit)56(135)*4259(19)49*477148(40)*6356
Net income (loss)163419*172243249240*182153231139*238198
Earnings per share, basic USD per share0.782.02*0.841.181.231.20*0.920.771.170.71*1.221.03
Earnings per share, diluted USD per share0.772.01*0.841.181.231.20*0.910.771.160.70*1.221.03
Weighted average shares, basic millions of shares209208*205206202199*199198198197*195192
Weighted average shares, diluted millions of shares210209*206206203200*200198199198*196193

Balance sheet

CSV

Fiscal quarters (ZBH's year ends in late December)

In millions of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents2924163934205695261,3855571,293592424410
Accounts receivable1,3411,4421,4461,4181,4821,4811,5331,6111,5981,7041,7291,770
Inventory2,3232,3852,3882,3702,3692,2352,2442,4542,4842,2862,2472,270
Prepaid and other current assets416366404431445430428431460537563647
Total current assets4,3724,6104,6324,6394,8644,6725,5905,0545,8355,1204,9635,097
Property and equipment, net2,0322,0602,0912,1032,1072,0492,0652,1762,1942,2072,2122,237
Right-of-use asset—204———214———204——
Goodwill8,7108,8198,7928,8258,9128,9518,9899,7109,7029,9479,9329,920
Total assets21,21721,49721,45221,52021,72021,36522,18422,86523,48823,09222,72222,798
Accounts payable320411370342322195301349315303361352
Accrued liabilities—628———734———835——
Current portion of long-term debt3559009701,8781,7138636008206005871,1761,202
Total current liabilities2,0722,8572,7973,6083,5712,4512,2952,7002,4032,5842,8643,014
Long-term debt5,1274,8684,8263,9574,7385,3426,5766,7537,5136,9326,2956,278
Lease liability, non-current—174———190———176——
Total liabilities8,6999,0098,8468,7719,3378,8899,78010,33110,72210,38610,04010,165
Retained earnings10,01510,38510,50910,70310,90411,09511,23011,33511,51911,61111,80311,955
Total stockholders' equity12,51112,48112,59812,74112,37512,46812,39512,52512,75712,69812,67312,624
Total liabilities and equity21,21721,49721,45221,52021,72021,36522,18422,86523,48823,09222,72222,798
Common shares outstanding (cover page) millions of shares209205206204199199198198198196193191

Cash flows

CSV

Fiscal quarters (ZBH's year ends in late December)

In millions of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)163419*172243249240*182153231139*238198
Stock-based compensation16*25*2926*25*21*2021*25*24*2425*
Depreciation and amortization241*241*239243*251*264*254272*284*284*270271*
Net cash from operating activities338*588*228369*396*506*383378*419*517*359448*
Purchases of property and equipment84*63*5553*45*52*4550*55*75*3654*
Net cash from investing activities(166)*(221)*(195)(247)*(155)*(291)*(106)(1,384)*(163)*(322)*(159)(191)*
Share repurchases0*410*11486*596*72*2307*0*250*250251*
Dividends paid50*50*4949*49*48*4848*48*48*4747*
Net cash from financing activities(196)*(251)*(50)(92)*(102)*(241)*575164*484*(897)*(369)(271)*
Net change in cash(28)*124*(23)27*149*(44)*859(828)*736*(701)*(168)(14)*

Compare with peers

SIC 3842 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3842 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingQuarter
Zimmer Biomet Holdings4102,177448*190.7M 10-QJun 30, 2026
Baxter International1,9752,976558*517.3M 10-QSep 30, 2026
West Pharmaceutical Services464875190*69.7M 10-QSep 30, 2026
Insulet53580288*69.4M 10-QJun 30, 2026
Hologic2,1681,048230223.2M 10-QDec 27, 2025
STERIS4821,49336797.5M 10-QJun 30, 2026
Solventum4032,209227*170.2M 10-QJun 30, 2026
Medline2,3277,685715*not reported 10-QJun 27, 2026
Align Technology1,1031,056193*71.0M 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.